Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis

ClinicalTrials.gov ID: NCT02129660

Public ClinicalTrials.gov record NCT02129660. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind Vehicle-Controlled Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to assess the safety of 2 doses of glycopyrrolate compared to 2 doses of glycopyrronium and vehicle (5 treatment arms) for the treatment of axillary hyperhidrosis when applied once daily for 4 weeks followed by a 2-week post-dose period.

Study identification

NCT ID: NCT02129660
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Journey Medical Corporation; Industry
Enrollment: 105 participants

Conditions and interventions

Conditions

Hyperhidrosis

Interventions

Drug · Other

Eligibility (public fields only)

Age range: 18 Years to 99 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 2014 (Type not available)
Primary completion: Jan 2015 (Actual)
Completion: Jan 2015 (Actual)
Last update posted: Sep 17, 2025

2014 – 2015

United States locations

U.S. sites: 14
U.S. states: 10
U.S. cities: 13

Facility	City	State	ZIP	Site status
California Dermatology & Clinical Research Institute	Encinitas	California	92024	—
Center For Dermatology Clinical Research	Fremont	California	94538	—
Olympian Clinical Research	Tampa	Florida	33609	—
Kenneth R. Beer MD	West Palm Beach	Florida	33401	—
Shideler Clinical Research Center	Carmel	Indiana	46032	—
Saint Louis University Dermatology	St Louis	Missouri	63122	—
Haber Dermatology and Cosmetic Surgery	Beachwood	Ohio	44122	—
Rivergate Dermatology Clinical Research Center, PLLC	Goodlettsville	Tennessee	37072	—
DermResearch, Inc	Austin	Texas	78759	—
Dermatology Research Center, Inc.	Salt Lake City	Utah	84117	—
Virginia Clinical Research, Inc.	Norfolk	Virginia	23507	—
Dermatology Associates	Seattle	Washington	98101	—
Women's Clinical Research Center	Seattle	Washington	98105	—
Premier Clinical Research	Spokane	Washington	99204	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02129660, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 17, 2025 · Synced Oct 22, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02129660 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →